We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Sewage Testing Helps Track Illicit Drug Use

By HospiMedica staff writers
Posted on 12 Sep 2007
A screening test provides evidence of illicit drug abuse in drug residues and metabolites excreted in urine and flushed toward municipal sewage treatment plants.

Past estimates of illicit drug abuse in a community were based largely on surveys in which children and adults were asked about their use of illegal drugs. More...
Investigators knew that some participants in surveys were not giving honest replies, with individuals being reluctant to admit breaking the law.

The sewage screening approach could provide a fast, reliable, and inexpensive way to track trends in drug use at the local, regional, or state levels while preserving the anonymity of individuals, according to scientist Jennifer Field, Ph.D., an environmental chemist at Oregon State University (Corvallis, OR, USA), who works with colleagues at Oregon State University and at the University of Washington (Seattle, WA, USA).

Dr. Field reported that the screening method under development in her lab improves upon the utility of the laboratory tools currently used to identify traces and metabolites of drugs in such studies. Her lab is refining the technique to verify its accuracy for extremely low concentrations, the order of a few ng/l. Calculations of drug use based solely on byproducts found in water supplies, especially at low levels, can be subject to error, Dr. Field said. To address this issue, her lab is working to identify common indicators, or biomarkers, such as caffeine or nicotine that can be used to sharpen their calculations.

"A lot of things contribute to the flow in wastewater, including agricultural and industrial processes. By linking our illicit drug measurements to biomarkers related to measurable human activities, we could compensate for differences in flows that aren't related to human excretion,” said Dr. Field.

The screening test was described at the 234th national meeting of the American Chemical Society, which took place in Boston (MA, USA) in August 2007.


Related Links:
Oregon State University
University of Washington

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Imaging Table
Stille imagiQ2
Infant Incubator
OKM 801
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.